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Abstract
We have used in situ tapping mode atomic force microscopy (AFM) to study the structural morphology of two fragments
of the influenza hemagglutinin protein bound to supported bilayers. The two proteins that we studied are the bromelain-
cleaved hemagglutinin (BHA), corresponding to the full ectodomain of the hemagglutinin protein, and FHA2, the 127 amino
acid N-terminal fragment of the HA2 subunit of the hemagglutinin protein. While BHA is water soluble at neutral pH and is
known to bind to membranes via specific interactions with a viral receptor, FHA2 can only be solubilized in water with an
appropriate detergent. Furthermore, FHA2 is known to readily bind to membranes at neutral pH in the absence of a
receptor. Our in situ AFM studies demonstrated that, when bound to supported bilayers at neutral pH, both these proteins
are self-assembled as single trimeric molecules. In situ acidification resulted in further lateral association of the FHA2
without a large perturbation of the bilayer. In contrast, BHA remained largely unaffected by acidification, except in areas of
exposed mica where it is aggregated. Remarkably, these results are consistent with previous observations that FHA2
promotes membrane fusion while BHA only induces liposome leakage at low pH. The results presented here are the first
example of in situ imaging of the ectodomain of a viral envelope protein allowing characterization of the real-time self-
assembly of a membrane fusion protein. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
In£uenza virus hemagglutinin (HA) is a trimeric
protein with each monomer being comprised of two
disul¢de-linked polypeptide chains, HA1 and HA2.
The low pH form of HA promotes the fusion of the
viral envelope with an endosome membrane during
viral entry. The HA1 chain contains the receptor
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Abbreviations: AFM, atomic force microscopy; TMAFM,
tapping mode AFM; HA, in£uenza hemagglutinin; BHA, bro-
melain-cleaved HA; FHA2, residues 1^127 of the HA2 polypep-
tide chain of the in£uenza hemagglutinin; DOPC, dioleoylphos-
phatidylcholine; DOPE, dioleoylphosphatidylethanolamine
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binding domain, while the HA2 chain contains the
fusion peptide that inserts into the target membrane
[1]. The protein is attached to the membrane via a
single transmembrane helical segment in the HA2
subunit. HA was the ¢rst membrane fusion protein
to be successfully crystallized [2]. While single crys-
tals of the entire ectodomain of HA (BHA) could be
isolated at neutral pH, the low pH form of BHA
must be truncated in order to facilitate crystallization
[3]. Under acidic conditions but in the absence of
membranes, BHA is known to undergo a large con-
formational rearrangement resulting in a coiled-coil
structure that closely resembles that of other active
membrane fusion proteins [4].
Most of the information about the structure of
HA in a membrane environment comes from elec-
tron microscopy. Previous negative stain transmis-
sion electron microscopy and antibody binding stud-
ies have suggested that the in£uenza HA protein
inserts its fusion peptide into the viral membrane
[5]. Using cryo-electron microscopy, Shangguan and
coworkers showed that the kinetics of the acid-in-
duced conformational change in HA was too slow
to account for the pH dependence of fusion [6].
Cryo-electron microscopy has also been used to pos-
tulate a model for the structure of the intact HA
trimer [7].
BHA is a water-soluble protein that does not
spontaneously partition into a membrane lacking a
receptor at neutral pH. Under acidic conditions
BHA will spontaneously form rosettes in solution
[8]. The protein will bind speci¢cally to sialic acid-
containing membranes at neutral pH, owing to a
binding site on the HA1 subunit. At low pH BHA
is known to induce liposome leakage but not signi¢-
cant membrane fusion, and it rapidly becomes inac-
tivated [9]. The structure of the membrane-associated
protein and/or the actual extent of aggregation or
oligomerization at the membrane surface remain un-
known [8].
FHA2 is the major portion of the HA2 subunit of
BHA. It comprises the ¢rst 127 amino acids of the
ectodomain and has no receptor binding function.
Unlike BHA, in which the hydrophobic fusion pep-
tide is sequestered within the protein structure at
neutral pH, the fusion peptide of FHA2 is exposed
at the end of the coiled-coil region and FHA2 can
bind to membranes lacking a receptor at neutral pH
[10]. As with the holoprotein, FHA2 will form
trimers in solution [10]; however, similar to BHA,
the state of oligomerization of this construct on
membranes and its extent of oligomerization as a
function of pH are not known. Although FHA2 pro-
motes membrane fusion when measured with a lipid
mixing assay, this fusion is also leaky [11]. It remains
unclear as to why FHA2, which comprises only a
segment of the HA2 subunit, is more active in pro-
moting lipid mixing than BHA, which contains a
larger segment of HA2 as well as the HA1 subunit
and is more similar structurally to the HA of native
intact virus.
It has now been shown that FHA2 can induce
hemifusion of cells with a potency comparable to
that of the intact hemagglutinin [12]. The structure
of the membrane-bound HA or any of its fragments
is not known. At acidic pH, where the protein is
fusion-active, the only known HA-related crystal
structure is that of a truncated form of HA2 that
lacked the segments essential for fusogenic activity.
In situ atomic force microscopy (AFM) has been
used previously to study protein^lipid interactions
[13^17]. In the present work we have studied the
association of two di¡erent forms of the ectodomain
of the in£uenza HA at supported lipid bilayer inter-
faces as a function of pH and incubation time. These
studies are the ¢rst example of the application of
atomic force microscopy to a study of the properties
of the hemagglutinin protein of in£uenza virus. The
results provide direct evidence of di¡erent protein
aggregation phenomena at model lipid surfaces for
the BHA and FHA2 fragments of the in£uenza HA,
that may be relevant to their function.
2. Materials and methods
2.1. Materials
FHA2 from the X-31 strain of the in£uenza virus
was expressed in Escherichia coli BL21(DE3) as pre-
viously described [18]. The ¢nal preparation of
FHA2 was 100 WM peptide in 0.1% Triton X-100,
500 mM NaCl, 0.4 mM DTT, 1 mM EDTA, 1 mM
PMSF, 5 mM citrate^phosphate bu¡er, pH 7.0.
BHA, from the PR/8/34 strain of in£uenza virus,
was prepared by Spafas (Storrs, CT, USA) according
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to the procedure of Compans et al. [19]. Another
preparation of BHA, made by bromelain cleavage
of in£uenza A X-31, was kindly provided to us by
Drs. J.M. White and J.A. Gruenke.
All phospholipids used in this work were pur-
chased from Avanti Polar Lipids (Alabaster, AL,
USA). The ganglioside, GD1a, was purchased from
Dr. I. Mikhalyov (Moscow, Russia).
2.2. Preparation of samples for AFM
Lipids in the desired ratio were combined in a so-
lution of chloroform/methanol (2:1; v/v). For FHA2
studies, bilayers composed of equimolar amounts of
dioleoylphosphatidylcholine (DOPC), dioleoylphos-
phatidylethanolamine (DOPE) and cholesterol were
prepared; for BHA studies, the same lipid composi-
tion was used but containing an additional 5% of
ganglioside GD1a. The lipids were deposited on the
wall of a glass test tube by solvent evaporation under
a stream of nitrogen. Last traces of solvent were
removed under vacuum for 2 h. The ¢lm was hy-
drated with 5 mM HEPES, 5 mM MES, 5 mM citric
acid, 0.15 M NaCl and 1 mM EDTA, pH 7.4
(HEPES^MES^citrate) to give a ¢nal lipid suspen-
sion of 1 mg/ml. This suspension was then placed
in a bath type sonicator for approx. 20 min, until
the suspension became clear or only slightly hazy.
This lipid suspension was then applied to the surface
of freshly cleaved mica and the lipid allowed to ad-
here to the mica surface over a period of 10^20 min.
2.3. Atomic force microscopy
Solution tapping mode atomic force microscopy
(TMAFM) images were acquired on a Digital Instru-
ments Nanoscope IIIA MultiMode scanning probe
microscope (Digital Instruments, Santa Barbara,
CA, USA) using 120 Wm oxide-sharpened silicon ni-
tride V-shaped cantilevers installed in a combination
contact/tapping mode liquid £ow cell. The £ow cell
was ¢tted with inlet and outlet tubes to enable direct
£uid exchange during imaging. The AFM cantilevers
were irradiated with UV light prior to imaging to
remove any adventitious organic contaminants. The
AFM images were acquired using the E scanning
head, which has a maximum lateral scan area of
14.6 WmU14.6 Wm. All imaging was performed at
tip scan rates from 1.25 to 2 Hz, using cantilever
drive frequencies of approx. 8.9 kHz at ambient tem-
perature. All images were captured as 512U512 pixel
images and were low-pass ¢ltered. Feature size and
volumes were calculated using the Digital Instru-
ments Nanoscope software (version 4.21) and share-
ware image analysis program, NIH-Image (version
1.62). Supported bilayers were formed by directly
injecting approx. 500 Wl of the 1 mg/ml lipid suspen-
sion into the AFM £uid cell, previously sealed
against a piece of freshly cleaved mica and allowing
the vesicles to fuse in situ. The cell was £ushed with
bu¡er and reference TMAFM height and phase im-
ages acquired in protein-free HEPES^MES^citrate
bu¡er at pH 7.4 to con¢rm formation of stable lipid
bilayers. Approx. 500 Wl of the protein solution in
HEPES^MES^citrate bu¡er was added and the sam-
ple imaged again to obtain reference images of the
membrane-associated proteins. The solution of
FHA2 was diluted 100-fold from the stock and con-
tained only 0.001% Triton X-100. This concentration
of detergent is not su⁄cient to prevent insertion of
the protein into membranes or to inhibit fusion [11].
Since the AFM £uid cell volume is approx. 200 Wl,
we have ensured complete replacement of the origi-
nal imaging bu¡er prior to introducing the protein or
exchanging the bu¡er. The imaging bu¡er was then
exchanged by the direct addition of approx. 500 Wl of
a protein-free HEPES^MES^citrate bu¡er at pH 5.0
and the imaging reinitiated. At no time was the
AFM cell removed from the mica surface nor was
the lipid bilayer exposed to air.
Fig. 1. In situ tapping mode AFM images. (A) A bilayer com-
posed of DOPC:DOPE:cholesterol (1:1:1) at pH 7.4. (B) After
introduction of a concentrated solution of FHA2 (100 Wg/ml) at
pH 7.4, showing coverage of the bilayer surface with particles
of protein. Image sizes: 10 WmU10 Wm. Calibration bar: 2.86
Wm.
BBAMEM 78119 6-7-01 Cyaan Magenta Geel Zwart
R.F. Epand et al. / Biochimica et Biophysica Acta 1513 (2001) 167^175 169
3. Results
The in situ fusion of sonicated lipid vesicles com-
prising an equimolar mixture of DOPC, DOPE and
cholesterol ( þ 5% GD1a) to a mica surface resulted in
the formation of approx. 5 nm thick, planar bilayers,
substantially defect-free and £at on a molecular scale
(Fig. 1A). This surface, imaged initially in the pres-
ence of bu¡er at pH 7.4, was free of debris. The
direct addition of FHA2 to the AFM liquid cell re-
sulted in the deposition of ellipsoidal FHA2 mole-
cules on the bilayer. Using a solution of 100 Wg/ml
FHA2 at pH 7.4, many small particles were observed
on the bilayer surface (Fig. 1B). Using a more dilute
solution of FHA2 (10 Wg/ml) resulted in the sporadic
deposition of particles on the bilayer surface. This
allowed for a more accurate estimation of size of
an individual particle, which averaged approx.
7U14 nm with an overall thickness (or height) above
the bilayer surface of approx. 2 þ 0.6 nm. The length
is consistent with that observed by Wharton et al. [5]
using electron microscopy. Although AFM tip e¡ects
contribute to an overestimation of lateral feature di-
mensions, the measured vertical distances are largely
una¡ected by the imaging forces, provided appropri-
ate measures are taken to account for surface charge
and double-layer forces [20,21]. Previous work has
demonstrated that one can readily balance the forces
between the AFM tip and the surface of interest by
appropriate selection of the imaging £uid and thus
adjustment of the Hamaker constant [22]. Although
there is some heterogeneity, a large fraction of small-
er particles have dimensions consistent with FHA2
binding to the membrane surface as a single trimer.
We did not observe growth of the surface aggregates
with time under these neutral pH conditions. How-
ever, after several minutes at pH 7.4 the height of the
particles measured decreased to approx. 1 nm above
the bilayer surface, suggesting a tendency of the pro-
tein to sink into the bilayer with time.
Remarkably, upon in situ acidi¢cation, we ob-
served the direct association of the individual
FHA2 particles across the bilayer surface (Fig. 2A^
D). This association process at acidic pH progressed
over time. This recruitment of particles occurs de-
Fig. 3. Image section analysis. (A) Height of a particle of
FHA2, deposited from a 10 Wg/ml solution of FHA2 at pH 7.4,
with respect to the bilayer; particle height is 2 nm. (B) Aggre-
gates of FHA2 formed 52 min after acidi¢cation to pH 5 of
the same solution deposited in A; particle heights are 17 nm
(o¡ scale on the ¢gure), 6.5 nm and 5 nm.
Fig. 2. In situ tapping mode AFM images of the FHA2 aggre-
gates on a DOPC:DOPE:cholesterol (1:1:1) bilayer formed
over mica. FHA2 was bound to the bilayer after being intro-
duced as a 10 Wg/ml solution at pH 7.4, and was then acidi¢ed
to pH 5.0. (A) 52 min after acidi¢cation, in height mode;
(B) 52 min after acidi¢cation, in phase mode; (C) 79 min after
acidi¢cation, in height mode; (D) 79 min after acidi¢cation, in
phase mode. Image sizes: 5 WmU5 Wm. Calibration bar: 1.20
Wm.
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spite the fact that the solution in contact with the
membrane was displaced by acidic bu¡er. Because of
the change in dimensionality between the two-dimen-
sional lipid surface and the three-dimensional volume
of solution above it, it would not require much re-
sidual protein in the supernatant to result in further
deposition to the membrane. Extensive washing of
the specimen could result in removal of some of
the protein that adhered at neutral pH. The height
of some of particles is shown for a 10 Wg/ml solution
of FHA2 at pH 7.4 (Fig. 3A) and at pH 5.0 (Fig.
3B). There is a marked change in both height and
heterogeneity of the particles at acidic pH, where
some of the larger aggregates reach a value of ap-
prox. 20 nm.
To complement our study of the FHA2 fragment,
two preparations of BHA were studied under similar
conditions. While BHA prepared from the X-31 in-
£uenza strain did not bind to the membrane at pH
7.4, in situ acidi¢cation with pH 5.0 protein-free
bu¡er led to the deposition of small BHA aggregates
on the membrane. The lack of BHA binding at pH
7.4 from this particular in£uenza strain can be ex-
plained by the greater speci¢city of this strain for
speci¢c sialolipids, particularly certain neolactogan-
gliosides [23]. However, the PR/8 strain of in£uenza
exhibits a lower speci¢city for binding to sialylated
moieties [23] and is known to bind to GD1a [24,25].
We ¢nd that when BHA is prepared from the PR/8
strain, binding does occur at neutral pH to mem-
branes containing GD1a (Fig. 4A). A typical BHA
particle appears as an oblate ellipsoid with an aver-
age diameter of approx. 17.5 nm in the plane of the
membrane and extending approx. 2 nm above the
plane of the membrane (Fig. 5B). The smooth, 5 nm
thick bilayer is shown for comparison (Fig. 5A). The
observed diameter of the BHA is consistent with a
diameter of 15 nm determined by electron microsco-
Fig. 5. Image section analysis of a bilayer composed of a
DOPC:DOPE:cholesterol (1:1:1) containing 5% GD1a. (A) A
break in the bilayer showing a 5 nm depth between the mica
and the bilayer surface. (B) Deposited BHA particles rising to
2 nm above the bilayer, at pH 7.4.
Fig. 4. In situ tapping mode AFM images of the BHA pre-
pared from PR/8 aggregates bound to the surface of a DOPC:-
DOPE:cholesterol (1:1:1) bilayer containing 5% GD1a. (A) At
pH 7.4 after adding to a bilayer deposited on mica. (B) 28 min
after acidi¢cation to pH 5. The darker regions in the upper
left-hand corner are defects in the approx. 5 nm thick lipid bi-
layer that expose the underlying mica substrate. (C) 116 min
after acidi¢cation. Note that the area of exposed mica is larger
in this image. Within this area one can observe protein par-
ticles. There are protein aggregates associated with either line
defects or larger regions of exposed mica. In addition, many
BHA particles whose size has not changed as a result of acidi¢-
cation are also present. (D) The identical image as in C but in
phase mode, rather than height mode, to clearly demonstrate
the line defects. Image sizes: (B,C,D) 5 WmU5 Wm; calibration
bar: 1.34 Wm; (A) 2 WmU2 Wm; calibration bar: 0.52 Wm.
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py [5] and it is of the order of magnitude expected
for a single BHA trimer.
In direct contrast to the results seen for the FHA2
fragment, exchange of the pH 7.4 imaging bu¡er
with a protein-free pH 5.0 bu¡er with the same
chemical composition did not drastically alter the
state of BHA oligomerization (Fig. 4B). The lack
of extensive aggregation of BHA at acidic pH is
not a consequence of the presence of GD1a in the
membrane, since we observe that this ganglioside
does not prevent the aggregation of FHA2 in the
membrane. At acidic pH, the two forms of BHA
made from di¡erent strains of in£uenza appear sim-
ilar, as does the underlying bilayer.
Upon acidi¢cation to pH 5 in the presence of
BHA, we observe the appearance of small bilayer
defects and holes (see upper left-hand corner of
Fig. 4B). With increased time these defects grow
and large aggregates of BHA form only in regions
close to these defects (Fig. 4C,D). The in situ acid-
i¢cation of the bilayer in the absence of BHA did not
result in bilayer disruption. There was no Triton used
in the experiment with BHA, thus the observed holes
were not caused by damage due to detergent. In ad-
dition, BHA at acidic pH also induces line defects
(Fig. 4C) that are also associated with aggregated
particles. The presence of these line defects is clearly
visible in the phase mode (Fig. 4D); they protrude
approx. 1 nm above the bilayer. There are also a few
large aggregates that may have moved away from the
defect regions. These defects are not likely to be
caused by the extended duration of imaging since
we ¢nd in all our experiments that this did not dam-
age the lipid bilayer or the adsorbed aggregates. We
cannot, however, entirely rule out that the sweeping
action of the imaging tip serves to increase convec-
tive £ow of soluble protein into the imaging frame.
However, low-resolution, large area scans did not
reveal any evidence of tip-induced aggregation. It
appears more likely then that the protein itself in-
duces these defects, although the mechanism by
which this occurs is not known.
4. Discussion
There are marked di¡erences in the aggregation
behavior of FHA2 and BHA as a function of pH.
While both constructs form trimers on the membrane
surface at neutral pH, the FHA2 underwent exten-
sive further lateral association on the bilayer upon
acidi¢cation of the medium. There is evidence to in-
dicate that in the absence of HA1, a single FHA2
trimer is in an extended coiled-coil conformation at
Fig. 6. Schematic diagram showing the relationship between the various proteins used in this work and the membrane at pH 7. Both
BHA and HA must initially be in a vertical orientation with respect to the plane of the membrane in order to bridge two membranes
to initiate fusion. Membrane, blue; fusion peptide, yellow; helical segments are colored green or red for visual contrast ; other poly-
peptide segments, black lines; globular domain of HA1, in green. Only in the case of HA are there two membranes, the viral mem-
brane and the target membrane. HA is oriented with its fusion peptide facing in the same direction as for FHA2. Note that this ori-
entation is not possible for BHA because it is attached to the membrane from the opposite end of the protein.
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both neutral and acidic pH. The fusion peptide of
FHA2 is an exposed hydrophobic segment that can
spontaneously enter the membrane at neutral pH as
indicated by spin labeling studies [10,18]. In contrast
to FHA2, the BHA protein is water-soluble and at
neutral pH will bind only to exposed sialic acid res-
idues at the membrane interface. Examination of the
crystal structure of BHA reveals that at neutral pH,
BHA will adopt a folded compact conformation [2].
Despite lack of evidence for a conformational
change in FHA2 upon acidi¢cation, this protein
undergoes extensive pH-dependent aggregation
(Fig. 2). This aggregation continues well beyond
the time required for liposome fusion [11]. It is
thus likely that this aggregation process is at least
in part associated with the process of inactivation
that is known to occur with FHA2 at acidic pH
[11]. The pH-dependent aggregation is likely to be
associated with the exposure of new hydrophobic
groups on this peptide, as has been demonstrated
by ANS binding [26]. These groups are in regions
other than the fusion peptide that is already exposed
at neutral pH.
The aggregation properties of BHA are quite dif-
ferent. There is little if any increase in size of BHA
upon acidi¢cation in regions in which the bilayer is
intact. ANS binding experiments indicate that acid-
i¢cation of BHA also leads to an increase in the
extent of exposure of hydrophobic groups [27]. How-
ever, the kinetics of increased ANS binding after
acidi¢cation is much slower for BHA than for
FHA2 [26] or for the intact HA [28]. In the case of
FHA2, the increased ANS binding with acidi¢cation
is not simply a consequence of the reduction of
charge repulsion since some constructs with single
amino acid replacements do not show this e¡ect
[26]. This slower exposure of hydrophobic groups
may be the cause for the di¡erent e¡ects on the
membrane. Upon acidi¢cation, BHA appeared to in-
itiate defects in the previously intact bilayer (Fig.
4B^D). This action would be consistent with the ob-
servation that BHA induces vesicle leakage at acidic
pH [9]. BHA, however, did form some aggregates
that appeared to be associated either with line defects
or with regions of exposed mica at low pH. Aggre-
gates are not observed prior to defect formation and
the ¢rst aggregates are seen within a region of ex-
posed mica. However, at longer times some aggre-
gates are observed outside of the region of exposed
mica, likely as a consequence of di¡usion subsequent
to their formation on the exposed mica surface. Re-
markably, BHA does not promote rapid lipid mixing
with liposomes of the same composition (unpub-
lished observations).
Our results suggest that a protein’s ability to ex-
pose hydrophobic residues and aggregate at acidic
pH is closely associated with its ability to enhance
membrane fusogenicity. Thus, FHA2 that aggregates
at low pH is also fusogenic at low pH, while BHA,
which is not fusogenic, appears not to aggregate on
the surface of the bilayer. Aggregation of the intact
HA protein has also been shown to be required for
fusion [29^32]. This initial aggregation to form small
clusters of HA is required for the formation of the
fusion intermediate, while more extensive aggrega-
tion at longer times is associated with inactivation
[33]. The di¡erence in aggregation behavior on the
surface of a membrane among FHA2, BHA and in-
tact HA can be understood in terms of the morpho-
logical relationship between the domain with which
the protein binds to a membrane and the location of
the fusion peptide relative to the membrane. The
spatial relationship of these constructs when bound
to a membrane at pH 7 is depicted in Fig. 6. The
fusion peptide is very hydrophobic and likely to be a
major factor in promoting protein aggregation. At
neutral pH the fusion peptide of FHA2 is thought
to be exposed, enabling this construct to bind to
membranes even prior to acidi¢cation [34]. It is these
neutral structures that, upon acidi¢cation, either
evolve into fusion intermediates or become inacti-
vated. Upon protonation, the fusion peptide already
in the membrane becomes more hydrophobic and
promotes protein association. This does not necessar-
ily mean that the fusion peptide itself aggregates in
the membrane and in fact the lack of extensive spin^
spin interaction between spin-labeled fusion peptides
of FHA2 indicates that this region of the protein is
monomeric [34]. There is evidence that another re-
gion of the protein, the kinked loop region of resi-
dues 108^115, may promote the low pH-induced ag-
gregation of FHA2 [18]. With intact HA the fusion
peptide is covered by the HA1 subunit and cannot
enter the membrane at neutral pH [35]. HA binds to
the target membrane through interaction of the HA1
subunit with receptor sites. No attempt was made to
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image the HA protein as it is a water-insoluble inte-
gral membrane protein and would have to be incor-
porated into the bilayer by other methods. However,
from the crystal structure one can appreciate that the
fusion peptide in the neutral pH form, although
buried within the protein structure, is only approx.
3 nm from the putative location of the transmem-
brane segment and hence the membrane into which
the HA is inserted [2]. Hence upon acidi¢cation the
fusion peptide can rapidly enter the membrane and
promote protein association in the same manner that
it does with FHA2. Insertion of the fusion peptide
into the viral membrane was recently hypothesized to
be of importance for the mechanism of fusion [36].
Of course there are di¡erences between the intact HA
and FHA2. It has been suggested that the energy
derived from the extension of the coiled coil in HA
can drive the formation of an energetically charged
dimple in the membrane [36]. This cannot be the
source of energy with FHA2 that is already in an
extended conformation at neutral pH. In addition,
FHA2 promotes only hemifusion, while HA facili-
tates full fusion. Nevertheless, there are a large num-
ber of similarities in the characteristics of the merger
caused by these two proteins [11,12]. In this work we
have shown that FHA2 tends to aggregate in mem-
branes at low pH, as has already been shown with
HA.
BHA has the same neutral pH conformation as the
ectodomain of the intact HA. However, unlike HA,
BHA is a water-soluble protein and has no hydro-
phobic attachment to the membrane. Like HA, BHA
also binds to the membrane through interactions be-
tween the HA1 subunit and sialic acid residues.
However, in this orientation the fusion peptide of
BHA is on the opposite side of the protein (Fig. 6),
approx. 8.5 nm from the membrane [2]. It is known
that in£uenza virus will be inactivated at lower pH in
the absence of target membrane [37]. Hence upon
acidi¢cation the fusion peptide aggregates outside
of the membrane and does not allow for protein
aggregates to bind to the membrane surface but
rather causes the formation of rosettes in solution
or of aggregates bound to defect regions in the case
of the supported bilayers. The present results would
thus suggest that the juxtaposition of the in£uenza
fusion peptide close to or within a membrane is an
important prerequisite for the promotion of fusion
by acidi¢cation.
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